A New Practical Decision Rule to Better Differentiate BI-RADS© 3 or 4 Breast Masses on Breast Ultrasound.

A New Practical Decision Rule to Better Differentiate BI-RADS© 3 or 4 Breast Masses on Breast Ultrasound.

Pfob A; Barr RG; Duda V; Büsch C; Bruckner T; Spratte J; Nees J; Togawa R; Ho C; Fastner S; Riedel F; Schaefgen B; Hennigs A; Sohn C; Heil J; Golatta M

Journal Of Ultrasound In Medicine

2021

2021-05-04

Patients were recruited as part of an international, multicenter trial (NCT02638935). The trial enrolled 1294 women (6 excluded) categorized as BI-RADS 3 or 4 upon routine B-mode ultrasound examination. Ultrasound images were evaluated by three expert physicians according to BI-RADS. All patients underwent histopathological confirmation (reference standard). We performed univariate and multivariate analyses (chi-square test, logistic regression, and Krippendorff's alpha).

The BI-RADS classification provides a standardized way to describe ultrasound findings in breast cancer diagnostics. However, there is little information regarding which BI-RADS descriptors are most strongly associated with malignancy, to better distinguish BI-RADS 3 (follow-up imaging) and 4 (diagnostic biopsy) breast masses.

Journal Article

427-436

2

41

NEOMED College of Medicine

Department of Radiology

2021 Jan to Aug List